Michael M. Meagher

St. Jude Children's Research Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

45h-index6.0kcitations149works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infectious Diseases and Gene Expression in Insects(36), CAR-T cell therapy research(31), Neuroblastoma Research and Treatments(20), Virus-based gene therapy research(19), Fungal and yeast genetics research(16)

Publications149 total

GO-8: Stable Expression of Factor VIII over 5 Years Following Adeno-Associated Gene Transfer in Subjects with Hemophilia a Using a Novel Human Factor VIII Variant
Blood·2023· 14 cited
Integrome signatures of lentiviral gene therapy for SCID-X1 patients
Science Advances·2023· 9 citedOpen Access
Abstracts From the NCCN 2023 Annual Conference
Journal of the National Comprehensive Cancer Network·2023Open Access
Supplementary Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Supplementary Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Supplementary Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Supplementary Figure from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Supplementary Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Supplementary Figure from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
2023Open Access
YIA23-003: CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response
Journal of the National Comprehensive Cancer Network·2023
Supplementary Table 4. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Supplementary Table 1. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Supplementary Table 2. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Supplementary Figure 3. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Data from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Data from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Supplementary Table 2. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
Supplementary Figure 1. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Mehmet İnan(12), Leonard A. Smith(8), Timothy Lockey(6), Robert W. Hutkins(6), Vijay Chiruvolu(5), Brandon M. Triplett(5), Stephen Gottschalk(5), Bradley A. Plantz(5), Sheng Zhou(4), Jayanta Sinha(4), Deanna Langfitt(4), Jean‐Yves Métais(4), Andrei G. Fadeev(3), Ben Youngblood(3), Nasib Qureshi(3), Wenhui Zhang(3), Vicki Schlegel(3), Amit C. Nathwani(3), Ulrike M. Reiss(3), Andrew M. Davidoff(3)